Micro-cap losers: Miller Energy Resources (NYSE:MILL), Biota Pharmaceuticals (NASDAQ:BOTA), Nova Lifestyle (NASDAQ:NVFY), Agria (NYSE:GRO)

Miller Energy Resources Inc. (NYSE:MILL) is adding a third rig to its Alaska drilling fleet. Tennessee-based Miller operates in Alaska via its Anchorage-based subsidiary, Cook Inlet Energy LLC. In filings with the U.S. Securities and Exchange Commission, Miller said it had entered into an option to purchase the rig for $3.25 million. The option is with Baker Hughes. Miller Energy Resources Inc (NYSE:MILL) stock performance … Continue reading Micro-cap losers: Miller Energy Resources (NYSE:MILL), Biota Pharmaceuticals (NASDAQ:BOTA), Nova Lifestyle (NASDAQ:NVFY), Agria (NYSE:GRO)

Biotech gainers: Insmed Incorporated (NASDAQ:INSM), Prothena Corporation (NASDAQ:PRTA), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Biota Pharmaceuticals (NASDAQ:BOTA)

Some days before, shares of Insmed Incorporated (NASDAQ:INSM) fell double digits after the company reported data on a 90 patient Phase 2 trial. Insmed Incorporated (NASDAQ:INSM) stock performance was 7.02% in last session and finished the day at $13.41. Traded volume was 1.55million shares in the last session and the average volume of the stock remained 788.23K shares. The beta of the stock remained 0.69. … Continue reading Biotech gainers: Insmed Incorporated (NASDAQ:INSM), Prothena Corporation (NASDAQ:PRTA), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Biota Pharmaceuticals (NASDAQ:BOTA)

Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) presented an update on the company at the 26th Annual ROTH Conference at 12:30 p.m. PDT, March 11, 2014, at The Ritz-Carlton, Dana Point in California. Biota Pharmaceuticals Inc (NASDAQ:BOTA) stock performance was 10.15% in last session and finished the day at $6.62. Traded volume was 449,674 million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Bullish Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Vermillion (NASDAQ:VRML), Genetic Technologies (NASDAQ:GENE)

Arca Biopharma Inc (NASDAQ:ABIO) focuses on developing genetically targeted therapies for cardiovascular disease. Its lead product candidate, Gencaro, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction. Arca Biopharma Inc (NASDAQ:ABIO) stock performance was 11.34% in last session and finished the day at $2.16. Traded volume … Continue reading Biotech Unusual Volume Stocks: Arca Biopharma (NASDAQ:ABIO), Biota Pharmaceuticals (NASDAQ:BOTA), Lpath (NASDAQ:LPTN), La Jolla Pharmaceutical (NASDAQ:LJPC)

Agenus Inc. (NASDAQ:AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. Agenus Inc. (NASDAQ:AGEN) stock performance was 0.00% in last session and finished the day at $4.89. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 1.12 million shares. The beta of the stock remained 1.33. … Continue reading Biotech Overbought Stocks: Agenus Inc. (NASDAQ:AGEN), Biota Pharmaceuticals (NASDAQ:BOTA), Albany Molecular Research (NASDAQ:AMRI), Sunesis Pharmaceuticals (NASDAQ:SNSS)

Microsoft has already made it clear that it’s planning to phase out the Nokia Corporation (ADR) (NYSE:NOK) name in its mobile products, and a newly leaked internal document confirms just that. The document, which was obtained by tech blog GeeksOnGadgets, reportedly says upcoming Nokia Lumia devices will soon be branded as just “Lumia.” Nokia Corporation (ADR) (NYSE:NOK) belongs to Technology sector. Its net profit margin … Continue reading Hot News: Nokia Corporation (ADR) (NYSE:NOK), STMicroelectronics NV (NYSE:STM), Radware Ltd. (NASDAQ:RDWR), Inuvo, Inc. (NYSEMKT:INUV), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA)